Answers are grounded in this paper and cite their sources.
STUDY QUESTION How does cleavage-stage nucleation status relate to blastocyst utilisation, euploidy, clinical pregnancy and live birth? SUMMARY ANSWER Abnormal two-cell nucleation was associated with reduced blastocyst utilisation, with a greater reduction for multinucleation than binucleation. WHAT IS KNOWN ALREADY Binucleation (two nuclei) and multinucleation (more than two nuclei) are relatively common during early embryo development, and some early nucleation abnormalities may later disappear. Although multinucleation has been associated with poorer embryo development, its relationship with blastocyst euploidy, pregnancy and live birth after blastocyst transfer remains uncertain. STUDY DESIGN, SIZE, DURATION A retrospective cohort study of all normally fertilised embryos from October 2019 to March 2025 was conducted. The cohort included 29 138 embryos from 2670 women and 4619 embryo-creation cycles. Pregnancy outcomes were assessed in 2862 single blastocyst transfers from 1610 women. PARTICIPANTS/MATERIALS, SETTING, METHODS Blastomere nucleation at the two- and four-cell stages was assessed using time-lapse monitoring and categorised as mononucleate (MONO, one nucleus), binucleate (BI, two nuclei), multinucleate (MULTI, > two nuclei) or unknown (UNKNOWN, unable to determine). For transferred embryos, the two blastomeres were assessed individually, allowing unilateral and bilateral BI and MULTI abnormalities to be distinguished. Blastocyst utilisation, euploidy among embryos undergoing preimplantation genetic testing for aneuploidy (PGT-A), and pregnancy and live birth rates following transfer were assessed. Mixed effects multivariable modelling was used, adjusting for female age, sperm-producing partner age, BMI, fertilisation method and time to first cell division. MAIN RESULTS AND THE ROLE OF CHANCE Two-cell nucleation status was strongly associated with early embryo development. Compared with mononucleated embryos, blastocyst utilisation was lower for binucleated embryos (adjusted relative risk (aRR) 0.81, 95% CI 0.77–0.86), multinucleated embryos (aRR 0.63, 95% CI 0.59–0.66) and embryos in which nucleation status could not be determined (aRR 0.40, 95% CI 0.37–0.43). Multinucleated embryos also had a modestly lower probability of euploidy (aRR 0.82, 95% CI 0.72–0.94). However, these early abnormalities were often not sustained, with 54% of binucleated embryos and 35% of multinucleated embryos subsequently classified as mononucleated at the four-cell stage. Importantly, once embryos had reached blastocyst stage and were selected for transfer, detailed two-cell nucleation pattern provided little additional prognostic information. There was no overall association with clinical pregnancy or live birth, including when bilateral binucleation and multinucleation were assessed in each individual blastomere. Findings were also consistent among euploid transfers and when fresh and frozen transfers were analysed separately. LIMITATIONS, REASONS FOR CAUTION The retrospective design introduces the possibility of selection bias and residual confounding, particularly as nucleation status may have influenced embryo prioritisation for transfer. Some blastomere-level subgroups were small, particularly among euploid transfers. The findings therefore describe associations between nucleation status and subsequent outcomes rather than establishing causality. WIDER IMPLICATIONS OF THE FINDINGS These findings are reassuring for patients with embryos previously classified as binucleated or multinucleated, particularly those with embryos already banked. Once an embryo has reached blastocyst stage and is selected for transfer, early nucleation status appears to have limited impact on the likelihood of pregnancy or live birth. As artificial intelligence and automated image analysis become more widely used, manual nucleation assessment may become less important, but will remain relevant for embryos created before these technologies were available and in settings where access to newer technologies is limited. FUNDING No funding was specifically received for this work. NP receives salary support from Mercy Perinatal and the Norman Beischer Research Foundation. DISCLOSURES No author has a conflict of interest to disclose. TRIAL REGISTRATION NUMBER N/A.
No takes yet. Share an insight, caveat, or question.
Pritchard et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: